Insulin resistance and altered insulin-like growth factor-1 (IGF-1) pathway activation, changes in bioavailability of sex hormones and a chronic inflammatory state related to obesity conditions have been recognized to induce cancer development and progression [12,13,14]. This evidence concerns the gene IGF1 and Insulin resistance.